Public Company News

AB Electrolux publishes 2022 Annual Report

STOCKHOLM, Feb. 23, 2023 /PRNewswire/ -- AB Electrolux Annual Report for 2022 has been published on the Group's website as of today. The Annual Report in Swedish as well as an English translation are available onwww.electroluxgroup.com in pdf-format and will be distributed in mid-March 2023 to s...

2023-02-23 16:10 2982

Citibank Singapore Appoints Matt Read as Retail Banking Head

Corporate veteran to build on good start to bank's bold wealth management goals SINGAPORE, Feb. 23, 2023 /PRNewswire/ -- Citi has named Matt Read as Citibank Singapore's Retail Banking Head, effectiveApril 17. Matt will lead the Singapore retail banking franchise, one of the global bank's largest...

2023-02-23 15:53 5502

Xspray Pharma Partners with EVERSANA® for the U.S. Launch and Commercialization of its Lead Product, Dasynoc (XS004) for the Treatment of Chronic Myeloid Leukemia (CML) and Acute Lymphatic Leukemia (ALL)

STOCKHOLM, Feb. 23, 2023 /PRNewswire/ -- Xspray Pharma AB, (NASDAQ Stockholm: XSPRAY) has signed an agreement with EVERSANA® to support the U.S. launch and commercialization of the company's first innovative cancer therapy Dasynoc for the treatment of chronic myeloid leukemia (CML) and acute lymp...

2023-02-23 15:02 2468

Queclink Launches Two Dual SIM LTE & Wi-Fi Routers for Fast and Secure Industrial Connectivity

SHANGHAI, Feb. 23, 2023 /PRNewswire/ -- Queclink Wireless Solutions , a global manufacturer of Internet of Things (IoT) hardware, announced the launch of two LTE Cat 4 industrial routers with dual SIM cards. The WR201LEU is available inEurope, and the WR201LG with GNSS ...

2023-02-23 14:12 3077

Keymed and Lepu Biopharma Jointly Announce Global Exclusive Licence Agreement with AstraZeneca for CMG901

CHENGDU, China, Feb. 23, 2023 /PRNewswire/ -- Keymed Biosciences Inc., ("Keymed") (Stock Code: 02162 HK) and Lepu Biopharma Co., Ltd, (Stock Code: 02157.HK) today jointly announce a global exclusive licence agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) for CMG901, a potential first-in-class C...

2023-02-23 13:01 2935

Lepu Biopharma and Keymed Jointly Announces Global Exclusive Licence Agreement with AstraZeneca for CMG901

HONG KONG, Feb. 22, 2023 /PRNewswire/ -- Lepu Biopharma Co., Ltd. (Stock Code: 02157.HK) and Keymed Biosciences Inc., ("Keymed") (Stock Code: 02162 HK) today jointly announces a global exclusive licence agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) for CMG901, a potential first-in-class Claudi...

2023-02-23 12:26 3638

IMAX CHINA REPORTS FULL-YEAR 2022 FINANCIAL RESULTS

GREATER CHINA HIGHLIGHTS (Note: Percentage and other changes refer to full-year 2021 unless otherwise noted) * Record-breaking start to 2023 with IMAX Chinese New Year box office of RMB231 million, up 54% year-over-year, led by 'The Wandering Earth 2' – now the highest-grossing local language ...

2023-02-23 08:14 6065

Electrolux Group has received a Statement of Objections from the French Competition Authority

STOCKHOLM, Feb. 23, 2023 /PRNewswire/ -- The French Competition Authority has issued a Statement of Objections involving various parties within the home appliance sector and where Electrolux France is alleged to have acted in breach of antitrust rules inFrance between 2009 and 2014. A Statement ...

2023-02-23 01:59 3205

MAXST will Showcase Metaverse Service Development Platform at MWC 2023

SEOUL, South Korea and BARCELONA, Spain, Feb. 22, 2023 /PRNewswire/ -- MAXST Co., Ltd., a company specializing in the metaverse platform, will participate in MWC 2023 (Mobile World Congress 2023), held inBarcelona, Spain from February 27 to March 2.

2023-02-22 22:00 3754

Altos Biologics, a Subsidiary of Alteogen, Completed Patient Enrollment in Global Phase 3 Clinical Trial of Eylea® Biosimilar in Neovascular Age-related Macular Degeneration

* Altos Biologics, a subsidiary of Alteogen, is actively engaged in Eylea®  Biosimilar (ALT-L9) clinical development and licensing-out discussions. * Early 2024 projected for Phase 3 completion and product launch in Europe expected after obtaining approval in the first half of 2025. DAEJEON, So...

2023-02-22 22:00 3729

Ajinomoto Bio-Pharma Services Successfully Develops Highly Functional Ancestral RNA Ligase

TOKYO, Feb. 22, 2023 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce the development of a new enzyme for double strand oligonucleotide formation with high productivity...

2023-02-22 21:05 3695

WiMi Hologram Cloud Develops MEC-Based Intelligent AR System Platform to Build Diversified Service System

BEIJING, Feb. 22, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that it has upgraded its existing AR cloud platform based on MEC and the integration of AI and AR techn...

2023-02-22 21:00 3028

AnPac Bio Announces Positive Results from its Multi-Year and Multi-Cancer Test Follow-Up Study

NEW YORK, Feb. 22, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio," the "Company" or "we") (ANPC), a company with operations inthe United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commer...

2023-02-22 20:30 3131

SM announces 2023 AGM Agenda and Board Nominees

Express Commitment to Enhancing Corporate Governance and Shareholder Value - Establishing a Board of Directors with the highest level of independence, diversity, and expertise in the country, without reappointment of current members - Accepting appropriate agendas from the shareholder's proposal...

2023-02-22 20:10 4359

TCL Ranked Global Top 2 TV Brand According to OMDIA

TCL reaffirms its pioneer in Mini LED and QLED TVs in 2023 with premium TV offerings HONG KONG, Feb. 22, 2023 /PRNewswire/ -- TCL, one of the dominant players in the global TV industry and a leading consumer electronics brand, announces its latest ranking of Global Top 2 TV Brand according to OM...

2023-02-22 20:04 4677

JJ-LAPP and Trina Solar Sign Strategic Cooperation Agreement, Forecast Doubling of Southeast Asia Business in 2023

SINGAPORE, Feb. 22, 2023 /PRNewswire/ -- JJ-LAPP , a joint-venture between Jebsen & Jessen Group and LAPP Holding Asia, andTrina Solar , a leading global PV and smart energy total solution provider, have signed a memorandum of understa...

2023-02-22 19:11 5144

China Yuchai Appoints New Director

SINGAPORE, Feb. 22, 2023 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD)("China Yuchai" or the "Company") wishes to announce that the Board of Directors of the Company has approved the appointment of Mr.Wong Hong Wai as a Director of China Yuchai with effect fromMarch 1, 2023.  Mr...

2023-02-22 19:00 3132

Bright Scholar Announces Appointment of Independent Director and Changes in Management

FOSHAN, China, Feb. 22, 2023 /PRNewswire/ -- Bright Scholar Education Holdings Limited ("Bright Scholar" or the "Company") (NYSE: BEDU), a global premier education service company, today announced appointment of an independent director to the board of directors of the Company (the "Board") and ch...

2023-02-22 19:00 4027

Hyundai Motor and Tate Announce El Anatsui as Next Hyundai Commission Artist

* El Anatsui, one of the most distinctive artists working today, to be the eighth Hyundai Commission artist for Tate Modern's Turbine Hall * New site-specific work to open to public on October 10, 2023 and remain on view throughApril 14, 2024 SEOUL, South Korea and LONDON, Feb. 22, 2023 /PRNe...

2023-02-22 18:00 3105

Trip.com Group Limited to Report Fourth Quarter and Full Year of 2022 Financial Results on March 6, 2023 U.S. Time

SHANGHAI, Feb. 22, 2023 /PRNewswire/ -- Trip.com Group Limited (Nasdaq: TCOM; HKEX: 9961), a leading one-stop travel service provider of accommodation reservation, transportation ticketing, packaged tours and corporate travel management, will announce its fourth quarter and full year of 2022 resu...

2023-02-22 18:00 4211